Home
Inbox
Search
Speaker
Lutz Wollin
PhD
Boehringer Ingelheim Pharma GmbH & Co. KG
Bookmark
Session(s)
The Matrix-Fibroblast Interplay: Nintedanib and Pirfenidone Modulate the Effect of IPF Fib...
Sunday, May 20
11:15 AM - 1:00 PM
Molecular Evidences for Antifibrotic Potentials of Nintedanib in Interstitial Lung Disease...
Tuesday, May 22
9:15 AM - 11:15 AM
Nintedanib Treatment Attenuates Pulmonary Fibrosis in A New Humanized Mouse Model for IPF ...
Tuesday, May 22
11:15 AM - 1:00 PM
Pirfenidone Attenuates Pro-Fibrotic Biomarker in Ex Vivo Lung Tissue Slices [Board No. P27...
Tuesday, May 22
11:15 AM - 1:00 PM
Home
Inbox
Search